Skip to content

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application

Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04670003
Acronym
SourceCOVID
Enrollment
4975
Registered
2020-12-17
Start date
2021-01-02
Completion date
2021-03-30
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases. Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.

Interventions

OTHERusers

Data of users of the web-application

Sponsors

Kelindi
CollaboratorINDUSTRY
Weprom
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* users of the application * not having objected to the use of their data

Exclusion criteria

\- user who does not have a complete questionnaire

Design outcomes

Primary

MeasureTime frameDescription
Description of the methods of contamination of patients2 monthsData and symptomes collected by the web applications self-questionnaire (patient reported outcome)

Secondary

MeasureTime frameDescription
Evaluation in time of the spread of the virus during the 2nd epidemic wave.2 monthsData and symptomes collected by the web applications self-questionnaire (patient reported outcome)
Evaluation in space of the spread of the virus during the 2nd epidemic wave.2 monthsData and symptomes collected by the web applications self-questionnaire according to ZIP code (patient reported outcome)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026